Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.07 -0.06 (-1.45%)
As of: Oct 1, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Non Operating Income (2020 - 2026)

Updated

Recursion Pharmaceuticals (RXRX) posted Non Operating Income of $3.96 million for Q2 2026, down 8.5% from $4.33 million a year earlier and down 38.1% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Non Operating Income (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Income at Recursion Pharmaceuticals was $20.54 million; for FY2025, it came in at $3.24 million, down 77.2% from FY2024.

  • In prior years, Recursion Pharmaceuticals' Non Operating Income was $14.22 million in FY2024 (-20.7%), $17.93 million in FY2023 (+186.9%), $6.25 million in FY2022 and -$3.7 million in FY2021.
  • Quarterly Non Operating Income has run from a low of -$11.28 million in Q1 2025 to a high of $9.95 million in Q3 2025 over five years.
  • On a year-over-year basis, Non Operating Income increased in three of the last six quarters, with growth averaging 57.2%.
  • The strongest year-over-year quarter for Non Operating Income in the past five years was Q2 2023, with growth of 690.6%; the weakest was Q4 2025, with a decline of 95.2%.
  • According to Business Quant data, Non Operating Income for the three prior quarters was $6.4 million (Q1 2026), $232,000 (Q4 2025) and $9.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Recursion Pharmaceuticals 2.21 Bn -397.37 Mn -3.82 Mn 3.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.96 Mn
Mar 31, 2026 6.40 Mn
Dec 31, 2025 232,000.00
Sep 30, 2025 9.95 Mn
Jun 30, 2025 4.33 Mn
Mar 31, 2025 -11.28 Mn
Dec 31, 2024 4.87 Mn
Sep 30, 2024 2.68 Mn
Jun 30, 2024 2.48 Mn
Mar 31, 2024 4.19 Mn
Dec 31, 2023 1.87 Mn
Sep 30, 2023 6.53 Mn
Jun 30, 2023 4.99 Mn
Mar 31, 2023 4.54 Mn
Dec 31, 2022 3.49 Mn
Sep 30, 2022 2.13 Mn
Jun 30, 2022 631,000.00
Mar 31, 2022 2,000.00
Dec 31, 2021 27,000.00
Sep 30, 2021 -1.03 Mn
API Access

Recursion Pharmaceuticals Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=RXRX&period=max&api_key=YOUR_API_KEY